MEI Pharma Inc (MEIP)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 0 0 0 0
Cost of Revenue 0 0 0 3,776,000
Gross Profit 0 0 0 -3,776,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,405,000 3,143,000 5,189,000 4,137,000
Operating Expenses 2,774,000 3,451,000 8,352,000 7,956,000
Operating Income -2,774,000 -3,451,000 -8,352,000 -18,980,000
Interest Expense 0 0 0 0
Income Before Tax -2,573,000 -2,677,000 -8,007,000 -18,406,000
Income Tax Expense 0 0 0 0
Net Income -2,573,000 -2,677,000 -8,007,000 -18,406,000
Per Share
EPS -0.39 -0.40 -1.20 -2.76
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue 0 65,297,000 48,816,000 40,697,000 25,535,000
Cost of Revenue 0 383,000 1,815,000 1,235,000 1,408,000
Gross Profit 0 64,914,000 47,001,000 39,462,000 24,127,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 13,532,000 23,295,000 33,130,000 30,540,000 24,414,000
Operating Expenses 17,455,000 50,755,000 85,580,000 116,181,000 93,812,000
Operating Income -17,455,000 14,542,000 -36,764,000 -75,484,000 -69,685,000
Interest Expense 0 0 0 284,000 0
Income Before Tax -15,945,000 17,778,000 -31,838,000 -54,454,000 -50,567,000
Income Tax Expense 0 0 -4,948,000 284,000 8,000
Net Income -15,945,000 17,778,000 -31,840,000 -54,738,000 -50,575,000
Per Share
EPS -2.39 2.67 -4.78 -8.80 -0.45
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 18,011,000 3,705,000 16,906,000 15,740,000
Short Term Investments 0 34,640,000 83,787,000 137,512,000
Net Receivables 0 0 85,000 10,044,000
Inventory 0 0 0 1
Total Current Assets 18,285,000 40,769,000 107,528,000 167,126,000
Property Plant Equipment 0 606,000 13,281,000 10,714,000
Goodwill and Intangibles 0 0 0 0
Total Assets 18,285,000 41,375,000 120,809,000 177,840,000
Liabilities
Account Payables 176,000 3,168,000 6,134,000 7,918,000
Short Term Debt 0 0 1,428,000 871,000
Total Current Liabilities 1,354,000 8,355,000 20,340,000 24,443,000
Long Term Debt 0 0 11,300,000 8,771,000
Total Liabilities 1,354,000 8,355,000 96,185,000 125,427,000
Shareholders Equity
Retained Earnings -404,164,000 -388,219,000 -405,997,000 -374,159,000
Total Shareholders Equity 16,931,000 33,020,000 24,624,000 52,413,000
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 18,011,000 3,705,000 16,906,000 15,740,000 8,543,000
Short Term Investments 0 34,640,000 83,787,000 137,512,000 144,883,000
Net Receivables 0 0 85,000 10,044,000 7,582,000
Inventory 0 0 0 1 0
Total Current Assets 18,285,000 40,769,000 107,528,000 167,126,000 164,817,000
Property Plant Equipment 0 606,000 13,281,000 10,714,000 9,281,000
Goodwill and Intangibles 0 0 0 0 0
Total Assets 18,285,000 41,375,000 120,809,000 177,840,000 174,098,000
Liabilities
Account Payables 176,000 3,168,000 6,134,000 7,918,000 6,355,000
Short Term Debt 0 0 1,428,000 871,000 928,000
Total Current Liabilities 1,354,000 8,355,000 20,340,000 24,443,000 30,294,000
Long Term Debt 0 0 11,300,000 8,771,000 7,370,000
Total Liabilities 1,354,000 8,355,000 96,185,000 125,427,000 132,736,000
Shareholders Equity
Retained Earnings -404,164,000 -388,219,000 -405,997,000 -374,159,000 -327,809,000
Total Shareholders Equity 16,931,000 33,020,000 24,624,000 52,413,000 41,362,000
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income -15,945,000 17,778,000 -31,838,000 -54,454,000
Depreciation & Amortization 368,000 383,000 386,000 326,000
Stock Based Compensation -144,000 2,278,000 3,589,000 8,350,000
Change in Working Capital 0 -84,276,000 -24,947,000 16,875,000
Operating Cash Flow -20,844,000 -50,473,000 -52,484,000 -48,746,000
Investing Activities
Capital Expenditure 0 -7,000 -35,000 -479,000
Investments 0 -7,000 -35,000 -479,000
Investing Cash Flow 35,150,000 49,140,000 53,690,000 6,892,000
Financing Activities
Debt Repayment 0 0 0 0
Common Stock Issued/Repurchased 0 0 -40,000 52,131,000
Dividends Paid 0 -11,660,000 0 0
Financing Cash Flow 0 -11,868,000 -40,000 49,051,000
Summary
Free Cash Flow -20,844,000 -50,480,000 -52,519,000 -49,225,000
Net Change in Cash 14,306,000 -13,201,000 1,166,000 7,197,000
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income -15,945,000 17,778,000 -31,838,000 -54,454,000 -50,575,000
Depreciation & Amortization 368,000 383,000 386,000 326,000 285,000
Stock Based Compensation -144,000 2,278,000 3,589,000 8,350,000 10,245,000
Change in Working Capital 0 -84,276,000 -24,947,000 16,875,000 26,203,000
Operating Cash Flow -20,844,000 -50,473,000 -52,484,000 -48,746,000 -31,964,000
Investing Activities
Capital Expenditure 0 -7,000 -35,000 -479,000 -708,000
Investments 0 -7,000 -35,000 -479,000 -708,000
Investing Cash Flow 35,150,000 49,140,000 53,690,000 6,892,000 24,708,000
Financing Activities
Debt Repayment 0 0 0 0 0
Common Stock Issued/Repurchased 0 0 -40,000 52,131,000 3,136,000
Dividends Paid 0 -11,660,000 0 0 0
Financing Cash Flow 0 -11,868,000 -40,000 49,051,000 3,468,000
Summary
Free Cash Flow -20,844,000 -50,480,000 -52,519,000 -49,225,000 -32,672,000
Net Change in Cash 14,306,000 -13,201,000 1,166,000 7,197,000 -3,788,000